XHRENADY Trademark

Trademark Overview


On Wednesday, September 14, 2022, a trademark application was filed for XHRENADY with the United States Patent and Trademark Office. The USPTO has given the XHRENADY trademark a serial number of 79352738. The federal status of this trademark filing is REGISTERED as of Tuesday, February 28, 2023. This trademark is owned by NOVARTIS AG. The XHRENADY trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
xhrenady

General Information


Serial Number79352738
Word MarkXHRENADY
Filing DateWednesday, September 14, 2022
Status700 - REGISTERED
Status DateTuesday, February 28, 2023
Registration Number6988201
Registration DateTuesday, February 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, May 16, 2023NOTIFICATION PROCESSED BY IB
Monday, April 17, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 17, 2023FINAL DISPOSITION PROCESSED
Thursday, March 30, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 20, 2022NOTIFICATION PROCESSED BY IB
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 30, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 7, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 7, 2022ASSIGNED TO EXAMINER
Tuesday, November 1, 2022APPLICATION FILING RECEIPT MAILED
Thursday, October 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 26, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 13, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB